ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP)

49,72
6,23
(14,33%)
Geschlossen 17 Februar 10:00PM
49,9299
0,2099
(0,42%)
Nach Börsenschluss: 1:59AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
49,9299
Gebot
49,73
Fragen
49,95
Volumen
7.484.206
46,21 Tagesbereich 52,5999
36,52 52-Wochen-Bereich 91,10
Marktkapitalisierung
Handelsende
43,49
Handelsbeginn
46,21
Letzter Handelszeitpunkt
Finanzvolumen
US$ 372.718.039
VWAP
49,8006
Durchschnittliches Volumen (3 Mio.)
1.877.183
Ausgegebene Aktien
85.774.474
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-27,76
Gewinn pro Aktie (EPS)
-1,79
Erlöse
371,21M
Nettogewinn
-153,61M

Über CRISPR Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specifi... CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Zug, Che
Gegründet
-
CRISPR Therapeutics AG is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRSP. The last closing price for CRISPR Therapeutics was US$43,49. Over the last year, CRISPR Therapeutics shares have traded in a share price range of US$ 36,52 to US$ 91,10.

CRISPR Therapeutics currently has 85.774.474 shares in issue. The market capitalisation of CRISPR Therapeutics is US$3,73 billion. CRISPR Therapeutics has a price to earnings ratio (PE ratio) of -27.76.

Option-Flow CRISPR Therapeutics (CRSP)

Gesamtfluss

Bullisch

Nettoprämie

2M

Calls / Puts

900,00%

Käuf. / Verkä.

110,53%

OTM / ITM

81,82%

Sweeps

2,50%

CRSP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
18.579920.749455864641.3549.997438.28233146241.58735136CS
48.539920.632761536641.3949.997438.28207247041.91646535CS
123.57997.7236245954746.3555.536.52187718343.47027228CS
261.42992.9482474226848.559.069336.52152039245.68555589CS
52-24.5401-32.953001208574.4791.136.52149863554.88605213CS
156-9.5801-16.098302806359.5191.136.52150817257.79757789CS
260-8.3401-14.312853955758.27220.2132145957177.80714186CS

CRSP - Frequently Asked Questions (FAQ)

What is the current CRISPR Therapeutics share price?
The current share price of CRISPR Therapeutics is US$ 49,9299
How many CRISPR Therapeutics shares are in issue?
CRISPR Therapeutics has 85.774.474 shares in issue
What is the market cap of CRISPR Therapeutics?
The market capitalisation of CRISPR Therapeutics is USD 3,73B
What is the 1 year trading range for CRISPR Therapeutics share price?
CRISPR Therapeutics has traded in the range of US$ 36,52 to US$ 91,10 during the past year
What is the PE ratio of CRISPR Therapeutics?
The price to earnings ratio of CRISPR Therapeutics is -27,76
What is the cash to sales ratio of CRISPR Therapeutics?
The cash to sales ratio of CRISPR Therapeutics is 11,49
What is the reporting currency for CRISPR Therapeutics?
CRISPR Therapeutics reports financial results in USD
What is the latest annual turnover for CRISPR Therapeutics?
The latest annual turnover of CRISPR Therapeutics is USD 371,21M
What is the latest annual profit for CRISPR Therapeutics?
The latest annual profit of CRISPR Therapeutics is USD -153,61M
What is the registered address of CRISPR Therapeutics?
The registered address for CRISPR Therapeutics is BAARERSTRASSE 14, ZUG, 6300
What is the CRISPR Therapeutics website address?
The website address for CRISPR Therapeutics is www.crisprtx.com
Which industry sector does CRISPR Therapeutics operate in?
CRISPR Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
101,64M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
248,48M
WRDWeRide Inc
US$ 31,4877
(83,39%)
20,57M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,67M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
134,88M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
425,19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,01M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
160,99k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,07M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock